Refinement of diagnostic assays for a probable causal mutation for porcine and human malignant hyperthermia.
Article Details
- CitationCopy to clipboard
Otsu K, Phillips MS, Khanna VK, de Leon S, MacLennan DH
Refinement of diagnostic assays for a probable causal mutation for porcine and human malignant hyperthermia.
Genomics. 1992 Jul;13(3):835-7.
- PubMed ID
- 1639409 [ View in PubMed]
- Abstract
The substitutions of T for C1843 in the porcine ryanodine receptor (RYR1) gene, which deletes a HinPI restriction endonuclease site and creates a HgiAI site, and of T for C1840 in human RYR1, which deletes a RsaI site, lead to Cys for Arg substitutions in the ryanodine receptors and are probable causal mutations for malignant hyperthermia (MH). To improve the restriction endonuclease assay of these sites, thereby providing an accurate, reliable diagnosis for MH, introns flanking the exon containing the mutation were sequenced, permitting identification and PCR amplification of a 659-bp porcine gene sequence that contains both constant and variant HgiAI sites and a 922-bp human gene sequence that contains both constant and variant RsaI sites. As a result, these PCR-amplified sequences contain constant internal controls for the reliable differentiation by restriction endonuclease digestion of normal, heterozygous, and MH genotypes.